{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T03:09:35Z","timestamp":1696907375734},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.transproceed.2005.02.022","type":"journal-article","created":{"date-parts":[[2005,4,21]],"date-time":"2005-04-21T11:40:57Z","timestamp":1114083657000},"page":"672-674","source":"Crossref","is-referenced-by-count":4,"title":["Open-Label, Multicenter Study on the Safety, Tolerability, and Efficacy of Simulect in Pediatric Renal Transplant Recipients Receiving Triple Therapy With Cyclosporin, Mycophenolate, and Corticosteroids"],"prefix":"10.1016","volume":"37","author":[{"given":"A.","family":"Turconi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Rodriguez Rilo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"de Boccardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Garsd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Otero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2005.02.022_bib1","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(97)09278-7","article-title":"Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group","volume":"350","author":"Nashan","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2005.02.022_bib2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00007890-199901270-00016","article-title":"Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody","volume":"67","author":"Kahan","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.02.022_bib3","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/00007890-200110150-00014","article-title":"A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients","volume":"72","author":"Ponticelli","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.02.022_bib4","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0041-1345(03)00578-5","article-title":"Immunoprophylaxis with Simulect (basiliximab) in pediatric kidney-transplant recipients: results from routine clinical practice at 5 kidney transplant units","volume":"35","author":"Garcia Meseguer","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2005.02.022_bib5","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/00007890-200210150-00011","article-title":"A rational dosing algorithm for basiliximab (Simulect) in pediatric renal transplantation based on pharmacokinetic-dynamic evaluations","volume":"74","author":"Kovarik","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.02.022_bib6","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/00007890-200210150-00010","article-title":"A multicenter, open-label, pharmacokinetic\/pharmacodynamic safety, and tolerability study of basiliximab (Simulect) in pediatric de novo renal transplant recipients","volume":"74","author":"Offner","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.02.022_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1034\/j.1399-3046.2000.00117.x","article-title":"A decade of living donor transplantation in North American children: the 1998 annual report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)","volume":"4","author":"McDonald","year":"2000","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.transproceed.2005.02.022_bib8","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1056\/NEJMp048125","article-title":"Pediatric renal-replacement therapy\u2014coming of age","volume":"350","author":"Dawn","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2005.02.022_bib9","unstructured":"North American Pediatric Renal Transplant Cooperative Study. 2003 Annual report: Available at: http:\/\/spitfire.emmes.com\/study\/ped\/resources\/annlrept.pdf. Accessed June 3, 2004"},{"key":"10.1016\/j.transproceed.2005.02.022_bib10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s004670100642","article-title":"Basiliximab induction improves the outcome of renal transplants in children and adolescents","volume":"16","author":"Swiatecka-Urban","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.transproceed.2005.02.022_bib11","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.transproceed.2003.10.087","article-title":"Triple immunosuppression with or without basiliximab in pediatric renal transplantation: acute rejection rates at one year","volume":"35","author":"Duzova","year":"2003","journal-title":"Transplant Proc"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134505001387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134505001387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T01:25:07Z","timestamp":1548552307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134505001387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0041134505001387"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2005.02.022","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}